The report provides a detailed analysis essential for establishing a Milbemycin production plant. It encompasses all critical aspects necessary for Milbemycin production, including the cost of Milbemycin production, Milbemycin plant cost, Milbemycin production costs, and the overall Milbemycin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Milbemycin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Milbemycin is an FDA-approved drug that actively acts against a broad spectrum of nematodes. It is extensively used as a medication for the treatment and prevention of heartworm disease and internal parasitic infections (e.g., hookworms, roundworms, etc.) in dogs and cats. Moreover, it also finds its application as endectocides and pesticides to control insects, mites, and pest infestations in crops due to its activity against endoparasites and insects. Additionally, it is also employed in aquaculture for controlling parasitic infections in fish populations.
The market for Milbemycin is driven by its usage as a potent anthelmintic for the treatment and prevention of a wide range of parasitic infections in animals, which significantly boosts its demand in the veterinary medicine industry. Moreover, its application as an insecticide for protecting crops such as fruits and vegetables from various insects and pests further promotes its demand in the agriculture sector. Furthermore, several factors influence industrial Milbemycin procurement, such as the availability of raw materials (S. hygroscopicus, fructose/Glucose), cost and pricing, regulatory compliance, supplier relationships, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Milbemycin Production
According to the Milbemycin production plant project report, the major raw materials for Milbemycin production include Streptomyces hygroscopicus-Fructose/Glucose.
Manufacturing Process of Milbemycin
The extensive Milbemycin production cost report consists of the following industrial production process:
- Production from Streptomyces hygroscopicus: This method of production involves the use of the strain of a new subspecies, S. hygroscopicus, that was derived from soil to produce milbemycin as the product through fermentation in high carbohydrate media. In this method, S. hygroscopicus is subjected to fermentation in the medium containing fructose or glucose, further increasing the concentration and maintaining a critical carbon: nitrogen ratio, which results in the production of milbemycin as the final product.
Milbemycin belongs to the class of 16-membered macrocyclic lactones. The molecular formula of the compound is C31H44O7, and its molecular weight is 528.7 g/mol. Moreover, the IUPAC name of the compound is (10Z,14Z)-21,24-dihydroxy-5',6',11,13,22-pentamethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one. Additionally, the drug milbemycin oxime is also classified as a macrocyclic anthelmintic.